Shukra Pharmaceuticals Ltd, formerly known as Relish Pharmaceuticals Limited, was established in March 1993 and rebranded in September 2016. The company specializes in the manufacturing of pharmaceutical products and laboratory testing. Its extensive product range includes various antibiotics, antivirals, antifungals, sedatives, analgesics, and other therapeutic categories, catering to a diverse client base.
Shukra Pharmaceuticals operates four manufacturing divisions located in Rakanpur, Gujarat, focusing on tablets, capsules, liquids, and small volume parenterals. The company serves prominent clients such as Cadila Healthcare Limited (Zydus), Intas Pharmaceuticals Limited, and Cadila Pharmaceuticals Limited, assisting in the development and manufacture of various drug forms and potencies. The company underwent a significant restructuring in FY 2013-14, merging with Proper Dealcomm Private Limited and reorganizing its share capital, as approved by the Gujarat High Court. This strategic move has reinforced its market position and operational capabilities.
